id	sid	tid	token	lemma	pos
dpc-1787	1	1	dermatology	dermatology	NOUN
dpc-1787	1	2	:	:	PUNCT
dpc-1787	1	3	practical	practical	ADJ
dpc-1787	1	4	and	and	CCONJ
dpc-1787	1	5	conceptual	conceptual	ADJ
dpc-1787	1	6	research	research	NOUN
dpc-1787	1	7	letter	letter	NOUN
dpc-1787	2	1	|	|	ADV
dpc-1787	2	2	dermatol	dermatol	ADJ
dpc-1787	2	3	pract	pract	NOUN
dpc-1787	2	4	concept	concept	NOUN
dpc-1787	2	5	.	.	PUNCT
dpc-1787	3	1	2022;12(2):e2022045	2022;12(2):e2022045	NUM
dpc-1787	3	2	1	1	NUM
dpc-1787	3	3	dermatology	dermatology	NOUN
dpc-1787	3	4	practical	practical	ADJ
dpc-1787	3	5	&	&	CCONJ
dpc-1787	3	6	conceptual	conceptual	ADJ
dpc-1787	3	7	introduction	introduction	NOUN
dpc-1787	3	8	selective	selective	ADJ
dpc-1787	3	9	cyclin	cyclin	NOUN
dpc-1787	3	10	-	-	PUNCT
dpc-1787	3	11	dependent	dependent	ADJ
dpc-1787	3	12	kinase	kinase	NOUN
dpc-1787	3	13	4/6	4/6	NUM
dpc-1787	3	14	inhibitors	inhibitor	NOUN
dpc-1787	3	15	(	(	PUNCT
dpc-1787	3	16	cdk	cdk	NOUN
dpc-1787	3	17	4/6i	4/6i	NUM
dpc-1787	3	18	)	)	PUNCT
dpc-1787	3	19	–	–	PUNCT
dpc-1787	3	20	ribociclib	ribociclib	NOUN
dpc-1787	3	21	,	,	PUNCT
dpc-1787	3	22	palbociclib	palbociclib	NOUN
dpc-1787	3	23	and	and	CCONJ
dpc-1787	3	24	abemaciclib	abemaciclib	PROPN
dpc-1787	3	25	–	–	PUNCT
dpc-1787	3	26	are	be	AUX
dpc-1787	3	27	a	a	DET
dpc-1787	3	28	novel	novel	ADJ
dpc-1787	3	29	therapeutic	therapeutic	ADJ
dpc-1787	3	30	option	option	NOUN
dpc-1787	3	31	for	for	ADP
dpc-1787	3	32	breast	breast	NOUN
dpc-1787	3	33	cancer	cancer	NOUN
dpc-1787	3	34	[	[	X
dpc-1787	3	35	1	1	NUM
dpc-1787	3	36	]	]	PUNCT
dpc-1787	3	37	.	.	PUNCT
dpc-1787	4	1	cdk	cdk	PROPN
dpc-1787	4	2	4/6is	4/6is	PRON
dpc-1787	4	3	are	be	AUX
dpc-1787	4	4	well	well	ADV
dpc-1787	4	5	tolerated	tolerate	VERB
dpc-1787	4	6	and	and	CCONJ
dpc-1787	4	7	have	have	AUX
dpc-1787	4	8	shown	show	VERB
dpc-1787	4	9	a	a	DET
dpc-1787	4	10	manageable	manageable	ADJ
dpc-1787	4	11	safety	safety	NOUN
dpc-1787	4	12	profile	profile	NOUN
dpc-1787	4	13	,	,	PUNCT
dpc-1787	4	14	with	with	ADP
dpc-1787	4	15	mild	mild	ADJ
dpc-1787	4	16	hematological	hematological	NOUN
dpc-1787	4	17	,	,	PUNCT
dpc-1787	4	18	gastrointestinal	gastrointestinal	ADJ
dpc-1787	4	19	and	and	CCONJ
dpc-1787	4	20	cutaneous	cutaneous	ADJ
dpc-1787	4	21	adverse	adverse	ADJ
dpc-1787	4	22	events	event	NOUN
dpc-1787	4	23	(	(	PUNCT
dpc-1787	4	24	ae	ae	PROPN
dpc-1787	4	25	)	)	PUNCT
dpc-1787	4	26	.	.	PUNCT
dpc-1787	5	1	vitiligo	vitiligo	VERB
dpc-1787	5	2	-	-	PUNCT
dpc-1787	5	3	like	like	ADJ
dpc-1787	5	4	lesions	lesion	NOUN
dpc-1787	5	5	are	be	AUX
dpc-1787	5	6	a	a	DET
dpc-1787	5	7	dermatologic	dermatologic	ADJ
dpc-1787	5	8	ae	ae	PROPN
dpc-1787	5	9	exceptionally	exceptionally	ADV
dpc-1787	5	10	reported	report	VERB
dpc-1787	5	11	with	with	ADP
dpc-1787	5	12	cdk	cdk	PROPN
dpc-1787	5	13	4/6is	4/6is	NUM
dpc-1787	5	14	use	use	NOUN
dpc-1787	5	15	[	[	X
dpc-1787	5	16	2	2	NUM
dpc-1787	5	17	]	]	PUNCT
dpc-1787	5	18	.	.	PUNCT
dpc-1787	6	1	case	case	NOUN
dpc-1787	6	2	presentation	presentation	NOUN
dpc-1787	6	3	a	a	DET
dpc-1787	6	4	70	70	NUM
dpc-1787	6	5	-	-	PUNCT
dpc-1787	6	6	year	year	NOUN
dpc-1787	6	7	-	-	PUNCT
dpc-1787	6	8	old	old	ADJ
dpc-1787	6	9	woman	woman	NOUN
dpc-1787	6	10	presented	present	VERB
dpc-1787	6	11	with	with	ADP
dpc-1787	6	12	a	a	DET
dpc-1787	6	13	6	6	NUM
dpc-1787	6	14	-	-	PUNCT
dpc-1787	6	15	week	week	NOUN
dpc-1787	6	16	history	history	NOUN
dpc-1787	6	17	of	of	ADP
dpc-1787	6	18	asymptomatic	asymptomatic	ADJ
dpc-1787	6	19	facial	facial	ADJ
dpc-1787	6	20	hypopigmented	hypopigmente	VERB
dpc-1787	6	21	spots	spot	NOUN
dpc-1787	6	22	.	.	PUNCT
dpc-1787	7	1	for	for	ADP
dpc-1787	7	2	the	the	DET
dpc-1787	7	3	last	last	ADJ
dpc-1787	7	4	8	8	NUM
dpc-1787	7	5	months	month	NOUN
dpc-1787	7	6	,	,	PUNCT
dpc-1787	7	7	she	she	PRON
dpc-1787	7	8	was	be	AUX
dpc-1787	7	9	receiving	receive	VERB
dpc-1787	7	10	treatment	treatment	NOUN
dpc-1787	7	11	with	with	ADP
dpc-1787	7	12	letrozole	letrozole	NOUN
dpc-1787	7	13	and	and	CCONJ
dpc-1787	7	14	ribociclib	ribociclib	NOUN
dpc-1787	7	15	for	for	ADP
dpc-1787	7	16	a	a	DET
dpc-1787	7	17	hormone	hormone	NOUN
dpc-1787	7	18	receptor	receptor	NOUN
dpc-1787	7	19	-	-	PUNCT
dpc-1787	7	20	positive	positive	ADJ
dpc-1787	7	21	(	(	PUNCT
dpc-1787	7	22	hr	hr	NOUN
dpc-1787	7	23	-	-	NOUN
dpc-1787	7	24	positive	positive	ADJ
dpc-1787	7	25	)	)	PUNCT
dpc-1787	7	26	and	and	CCONJ
dpc-1787	7	27	human	human	ADJ
dpc-1787	7	28	epidermal	epidermal	ADJ
dpc-1787	7	29	growth	growth	NOUN
dpc-1787	7	30	factor	factor	NOUN
dpc-1787	7	31	receptor-2	receptor-2	NOUN
dpc-1787	7	32	-	-	PUNCT
dpc-1787	7	33	negative	negative	ADJ
dpc-1787	7	34	(	(	PUNCT
dpc-1787	7	35	her2	her2	NOUN
dpc-1787	7	36	-	-	PUNCT
dpc-1787	7	37	negative	negative	ADJ
dpc-1787	7	38	)	)	PUNCT
dpc-1787	7	39	metastatic	metastatic	ADJ
dpc-1787	7	40	breast	breast	NOUN
dpc-1787	7	41	cancer	cancer	NOUN
dpc-1787	7	42	.	.	PUNCT
dpc-1787	8	1	dermatological	dermatological	ADJ
dpc-1787	8	2	examination	examination	NOUN
dpc-1787	8	3	revealed	reveal	VERB
dpc-1787	8	4	unpigmented	unpigmented	ADJ
dpc-1787	8	5	,	,	PUNCT
dpc-1787	8	6	well	well	ADV
dpc-1787	8	7	-	-	PUNCT
dpc-1787	8	8	defined	define	VERB
dpc-1787	8	9	macules	macule	NOUN
dpc-1787	8	10	distributed	distribute	VERB
dpc-1787	8	11	symmetrically	symmetrically	ADV
dpc-1787	8	12	in	in	ADP
dpc-1787	8	13	the	the	DET
dpc-1787	8	14	neck	neck	NOUN
dpc-1787	8	15	and	and	CCONJ
dpc-1787	8	16	the	the	DET
dpc-1787	8	17	face	face	NOUN
dpc-1787	8	18	,	,	PUNCT
dpc-1787	8	19	with	with	ADP
dpc-1787	8	20	affectation	affectation	NOUN
dpc-1787	8	21	of	of	ADP
dpc-1787	8	22	hair	hair	NOUN
dpc-1787	8	23	follicle	follicle	NOUN
dpc-1787	8	24	(	(	PUNCT
dpc-1787	8	25	figure	figure	NOUN
dpc-1787	8	26	1	1	NUM
dpc-1787	8	27	,	,	PUNCT
dpc-1787	8	28	a	a	PRON
dpc-1787	8	29	and	and	CCONJ
dpc-1787	8	30	b	b	NOUN
dpc-1787	8	31	)	)	PUNCT
dpc-1787	8	32	.	.	PUNCT
dpc-1787	9	1	the	the	DET
dpc-1787	9	2	wood	wood	NOUN
dpc-1787	9	3	lamp	lamp	NOUN
dpc-1787	9	4	examination	examination	NOUN
dpc-1787	9	5	showed	show	VERB
dpc-1787	9	6	bright	bright	ADJ
dpc-1787	9	7	white	white	ADJ
dpc-1787	9	8	and	and	CCONJ
dpc-1787	9	9	sharply	sharply	ADV
dpc-1787	9	10	delineated	delineate	VERB
dpc-1787	9	11	lesions	lesion	NOUN
dpc-1787	9	12	(	(	PUNCT
dpc-1787	9	13	figure	figure	NOUN
dpc-1787	9	14	2	2	NUM
dpc-1787	9	15	)	)	PUNCT
dpc-1787	9	16	.	.	PUNCT
dpc-1787	10	1	based	base	VERB
dpc-1787	10	2	on	on	ADP
dpc-1787	10	3	these	these	DET
dpc-1787	10	4	findings	finding	NOUN
dpc-1787	10	5	,	,	PUNCT
dpc-1787	10	6	a	a	DET
dpc-1787	10	7	diagnosis	diagnosis	NOUN
dpc-1787	10	8	of	of	ADP
dpc-1787	10	9	vitiligo	vitiligo	NOUN
dpc-1787	10	10	was	be	AUX
dpc-1787	10	11	made	make	VERB
dpc-1787	10	12	.	.	PUNCT
dpc-1787	11	1	discussion	discussion	NOUN
dpc-1787	11	2	vitiligo	vitiligo	NOUN
dpc-1787	11	3	is	be	AUX
dpc-1787	11	4	an	an	DET
dpc-1787	11	5	acquired	acquire	VERB
dpc-1787	11	6	pigmentary	pigmentary	ADJ
dpc-1787	11	7	autoimmune	autoimmune	ADJ
dpc-1787	11	8	disorder	disorder	NOUN
dpc-1787	11	9	consisting	consist	VERB
dpc-1787	11	10	of	of	ADP
dpc-1787	11	11	the	the	DET
dpc-1787	11	12	development	development	NOUN
dpc-1787	11	13	of	of	ADP
dpc-1787	11	14	hypopigmented	hypopigmente	VERB
dpc-1787	11	15	macules	macule	NOUN
dpc-1787	11	16	due	due	ADP
dpc-1787	11	17	to	to	ADP
dpc-1787	11	18	the	the	DET
dpc-1787	11	19	selective	selective	ADJ
dpc-1787	11	20	loss	loss	NOUN
dpc-1787	11	21	of	of	ADP
dpc-1787	11	22	melanocytes	melanocyte	NOUN
dpc-1787	11	23	.	.	PUNCT
dpc-1787	12	1	the	the	DET
dpc-1787	12	2	cause	cause	NOUN
dpc-1787	12	3	of	of	ADP
dpc-1787	12	4	vitiligo	vitiligo	NOUN
dpc-1787	12	5	remains	remain	VERB
dpc-1787	12	6	unknown	unknown	ADJ
dpc-1787	12	7	.	.	PUNCT
dpc-1787	13	1	vitiligo	vitiligo	VERB
dpc-1787	13	2	-	-	PUNCT
dpc-1787	13	3	like	like	ADJ
dpc-1787	13	4	lesions	lesion	NOUN
dpc-1787	13	5	have	have	AUX
dpc-1787	13	6	been	be	AUX
dpc-1787	13	7	reported	report	VERB
dpc-1787	13	8	as	as	ADP
dpc-1787	13	9	an	an	DET
dpc-1787	13	10	ae	ae	PROPN
dpc-1787	13	11	in	in	ADP
dpc-1787	13	12	oncological	oncological	ADJ
dpc-1787	13	13	patients	patient	NOUN
dpc-1787	13	14	treated	treat	VERB
dpc-1787	13	15	with	with	ADP
dpc-1787	13	16	anti	anti	ADJ
dpc-1787	13	17	-	-	ADJ
dpc-1787	13	18	programmed	programmed	ADJ
dpc-1787	13	19	death-1/	death-1/	NOUN
dpc-1787	13	20	programmed	program	VERB
dpc-1787	13	21	death	death	NOUN
dpc-1787	13	22	-	-	PUNCT
dpc-1787	13	23	ligand	ligand	NOUN
dpc-1787	13	24	1	1	NUM
dpc-1787	13	25	(	(	PUNCT
dpc-1787	13	26	pd-1	pd-1	NOUN
dpc-1787	13	27	/	/	SYM
dpc-1787	13	28	pd	pd	NOUN
dpc-1787	13	29	-	-	PUNCT
dpc-1787	13	30	l1	l1	NOUN
dpc-1787	13	31	)	)	PUNCT
dpc-1787	13	32	immunotherapies	immunotherapy	NOUN
dpc-1787	13	33	(	(	PUNCT
dpc-1787	13	34	pembrolizumab	pembrolizumab	NOUN
dpc-1787	13	35	,	,	PUNCT
dpc-1787	13	36	nivolumab	nivolumab	NOUN
dpc-1787	13	37	)	)	PUNCT
dpc-1787	13	38	,	,	PUNCT
dpc-1787	13	39	as	as	ADV
dpc-1787	13	40	well	well	ADV
dpc-1787	13	41	as	as	ADP
dpc-1787	13	42	in	in	ADP
dpc-1787	13	43	patients	patient	NOUN
dpc-1787	13	44	treated	treat	VERB
dpc-1787	13	45	with	with	ADP
dpc-1787	13	46	tyrosine	tyrosine	NOUN
dpc-1787	13	47	-	-	PUNCT
dpc-1787	13	48	kinase	kinase	NOUN
dpc-1787	13	49	inhibitors	inhibitor	NOUN
dpc-1787	13	50	(	(	PUNCT
dpc-1787	13	51	imatinib	imatinib	NOUN
dpc-1787	13	52	,	,	PUNCT
dpc-1787	13	53	cabozantinib	cabozantinib	ADV
dpc-1787	13	54	,	,	PUNCT
dpc-1787	13	55	pazopanib	pazopanib	PROPN
dpc-1787	13	56	)	)	PUNCT
dpc-1787	14	1	[	[	X
dpc-1787	14	2	2	2	NUM
dpc-1787	14	3	]	]	PUNCT
dpc-1787	14	4	.	.	PUNCT
dpc-1787	15	1	it	it	PRON
dpc-1787	15	2	is	be	AUX
dpc-1787	15	3	considered	consider	VERB
dpc-1787	15	4	an	an	DET
dpc-1787	15	5	indicator	indicator	NOUN
dpc-1787	15	6	of	of	ADP
dpc-1787	15	7	survival	survival	NOUN
dpc-1787	15	8	benefit	benefit	NOUN
dpc-1787	15	9	in	in	ADP
dpc-1787	15	10	melanoma	melanoma	NOUN
dpc-1787	15	11	patients	patient	NOUN
dpc-1787	15	12	treated	treat	VERB
dpc-1787	15	13	with	with	ADP
dpc-1787	15	14	anti	anti	ADJ
dpc-1787	15	15	-	-	ADJ
dpc-1787	15	16	pd-1	pd-1	ADJ
dpc-1787	15	17	/	/	SYM
dpc-1787	15	18	pd	pd	NOUN
dpc-1787	15	19	-	-	PUNCT
dpc-1787	15	20	l1	l1	PROPN
dpc-1787	15	21	immunotherapies	immunotherapy	NOUN
dpc-1787	15	22	.	.	PUNCT
dpc-1787	16	1	selective	selective	ADJ
dpc-1787	16	2	cdk	cdk	PROPN
dpc-1787	16	3	4/6is	4/6is	PRON
dpc-1787	16	4	are	be	AUX
dpc-1787	16	5	currently	currently	ADV
dpc-1787	16	6	approved	approve	VERB
dpc-1787	16	7	by	by	ADP
dpc-1787	16	8	the	the	DET
dpc-1787	16	9	us	us	PROPN
dpc-1787	16	10	food	food	NOUN
dpc-1787	16	11	and	and	CCONJ
dpc-1787	16	12	drug	drug	NOUN
dpc-1787	16	13	administration	administration	NOUN
dpc-1787	16	14	and	and	CCONJ
dpc-1787	16	15	the	the	DET
dpc-1787	16	16	european	european	PROPN
dpc-1787	16	17	medicines	medicine	NOUN
dpc-1787	16	18	agency	agency	NOUN
dpc-1787	16	19	for	for	ADP
dpc-1787	16	20	the	the	DET
dpc-1787	16	21	treatment	treatment	NOUN
dpc-1787	16	22	of	of	ADP
dpc-1787	16	23	patients	patient	NOUN
dpc-1787	16	24	with	with	ADP
dpc-1787	16	25	hr	hr	NOUN
dpc-1787	16	26	-	-	NOUN
dpc-1787	16	27	positive	positive	ADJ
dpc-1787	16	28	,	,	PUNCT
dpc-1787	16	29	her2	her2	NOUN
dpc-1787	16	30	-	-	PUNCT
dpc-1787	16	31	negative	negative	ADJ
dpc-1787	16	32	advanced	advanced	ADJ
dpc-1787	16	33	or	or	CCONJ
dpc-1787	16	34	metastatic	metastatic	ADJ
dpc-1787	16	35	breast	breast	NOUN
dpc-1787	16	36	cancer	cancer	NOUN
dpc-1787	16	37	.	.	PUNCT
dpc-1787	17	1	hematologic	hematologic	NOUN
dpc-1787	17	2	toxicity	toxicity	NOUN
dpc-1787	17	3	,	,	PUNCT
dpc-1787	17	4	gastrointestinal	gastrointestinal	ADJ
dpc-1787	17	5	disturbances	disturbance	NOUN
dpc-1787	17	6	and	and	CCONJ
dpc-1787	17	7	fatigue	fatigue	NOUN
dpc-1787	17	8	are	be	AUX
dpc-1787	17	9	the	the	DET
dpc-1787	17	10	most	most	ADV
dpc-1787	17	11	frequent	frequent	ADJ
dpc-1787	17	12	side	side	NOUN
dpc-1787	17	13	effects	effect	NOUN
dpc-1787	17	14	of	of	ADP
dpc-1787	17	15	this	this	DET
dpc-1787	17	16	class	class	NOUN
dpc-1787	17	17	of	of	ADP
dpc-1787	17	18	agents	agent	NOUN
dpc-1787	17	19	[	[	X
dpc-1787	17	20	1	1	NUM
dpc-1787	17	21	]	]	PUNCT
dpc-1787	17	22	.	.	PUNCT
dpc-1787	18	1	the	the	DET
dpc-1787	18	2	most	most	ADV
dpc-1787	18	3	common	common	ADJ
dpc-1787	18	4	dermatological	dermatological	ADJ
dpc-1787	18	5	adverse	adverse	ADJ
dpc-1787	18	6	event	event	NOUN
dpc-1787	18	7	is	be	AUX
dpc-1787	18	8	alopecia	alopecia	NOUN
dpc-1787	18	9	,	,	PUNCT
dpc-1787	18	10	which	which	PRON
dpc-1787	18	11	might	might	AUX
dpc-1787	18	12	be	be	AUX
dpc-1787	18	13	increased	increase	VERB
dpc-1787	18	14	by	by	ADP
dpc-1787	18	15	the	the	DET
dpc-1787	18	16	association	association	NOUN
dpc-1787	18	17	of	of	ADP
dpc-1787	18	18	endocrine	endocrine	PROPN
dpc-1787	18	19	therapy	therapy	NOUN
dpc-1787	18	20	.	.	PUNCT
dpc-1787	19	1	moreover	moreover	ADV
dpc-1787	19	2	,	,	PUNCT
dpc-1787	19	3	pruritus	pruritus	PROPN
dpc-1787	19	4	and	and	CCONJ
dpc-1787	19	5	a	a	DET
dpc-1787	19	6	maculopapular	maculopapular	ADJ
dpc-1787	19	7	rash	rash	NOUN
dpc-1787	19	8	have	have	AUX
dpc-1787	19	9	also	also	ADV
dpc-1787	19	10	been	be	AUX
dpc-1787	19	11	reported	report	VERB
dpc-1787	19	12	as	as	ADP
dpc-1787	19	13	cutaneous	cutaneous	ADJ
dpc-1787	19	14	adverse	adverse	ADJ
dpc-1787	19	15	reactions	reaction	NOUN
dpc-1787	19	16	in	in	ADP
dpc-1787	19	17	patients	patient	NOUN
dpc-1787	19	18	treated	treat	VERB
dpc-1787	19	19	with	with	ADP
dpc-1787	19	20	ribociclib	ribociclib	NOUN
dpc-1787	19	21	[	[	X
dpc-1787	19	22	1,2	1,2	NUM
dpc-1787	19	23	]	]	PUNCT
dpc-1787	19	24	.	.	PUNCT
dpc-1787	20	1	ribociclib	ribociclib	NOUN
dpc-1787	20	2	-	-	PUNCT
dpc-1787	20	3	induced	induce	VERB
dpc-1787	20	4	vitiligo	vitiligo	NOUN
dpc-1787	20	5	:	:	PUNCT
dpc-1787	20	6	a	a	DET
dpc-1787	20	7	case	case	NOUN
dpc-1787	20	8	report	report	NOUN
dpc-1787	20	9	nicolás	nicolás	NOUN
dpc-1787	20	10	silvestre	silvestre	PROPN
dpc-1787	20	11	torner1	torner1	PROPN
dpc-1787	20	12	,	,	PUNCT
dpc-1787	20	13	antonio	antonio	PROPN
dpc-1787	20	14	aguilar	aguilar	PROPN
dpc-1787	20	15	martínez1	martínez1	PROPN
dpc-1787	20	16	,	,	PUNCT
dpc-1787	20	17	maría	maría	PROPN
dpc-1787	20	18	josé	josé	PROPN
dpc-1787	20	19	echarri	echarri	PROPN
dpc-1787	20	20	gonzález2	gonzález2	PROPN
dpc-1787	20	21	,	,	PUNCT
dpc-1787	20	22	sergio	sergio	PROPN
dpc-1787	20	23	tabbara	tabbara	PROPN
dpc-1787	20	24	carrascosa1	carrascosa1	PROPN
dpc-1787	20	25	,	,	PUNCT
dpc-1787	20	26	jorge	jorge	PROPN
dpc-1787	20	27	román	román	PROPN
dpc-1787	20	28	sainz1	sainz1	PROPN
dpc-1787	20	29	,	,	PUNCT
dpc-1787	20	30	fernando	fernando	PROPN
dpc-1787	20	31	gruber	gruber	PROPN
dpc-1787	20	32	velasco1	velasco1	PROPN
dpc-1787	20	33	1	1	NUM
dpc-1787	20	34	department	department	NOUN
dpc-1787	20	35	of	of	ADP
dpc-1787	20	36	dermatology	dermatology	NOUN
dpc-1787	20	37	,	,	PUNCT
dpc-1787	20	38	hospital	hospital	NOUN
dpc-1787	20	39	universitario	universitario	PROPN
dpc-1787	20	40	severo	severo	PROPN
dpc-1787	20	41	ochoa	ochoa	PROPN
dpc-1787	20	42	,	,	PUNCT
dpc-1787	20	43	leganés	leganés	PROPN
dpc-1787	20	44	(	(	PUNCT
dpc-1787	20	45	madrid	madrid	PROPN
dpc-1787	20	46	)	)	PUNCT
dpc-1787	20	47	,	,	PUNCT
dpc-1787	20	48	spain	spain	PROPN
dpc-1787	20	49	.	.	PUNCT
dpc-1787	21	1	2	2	NUM
dpc-1787	21	2	department	department	NOUN
dpc-1787	21	3	of	of	ADP
dpc-1787	21	4	oncology	oncology	NOUN
dpc-1787	21	5	,	,	PUNCT
dpc-1787	21	6	hospital	hospital	NOUN
dpc-1787	21	7	universitario	universitario	PROPN
dpc-1787	21	8	severo	severo	PROPN
dpc-1787	21	9	ochoa	ochoa	PROPN
dpc-1787	21	10	,	,	PUNCT
dpc-1787	21	11	leganés	leganés	PROPN
dpc-1787	21	12	(	(	PUNCT
dpc-1787	21	13	madrid	madrid	PROPN
dpc-1787	21	14	)	)	PUNCT
dpc-1787	21	15	,	,	PUNCT
dpc-1787	21	16	spain	spain	PROPN
dpc-1787	21	17	.	.	PUNCT
dpc-1787	22	1	key	key	ADJ
dpc-1787	22	2	words	word	NOUN
dpc-1787	22	3	:	:	PUNCT
dpc-1787	22	4	vitiligo	vitiligo	NOUN
dpc-1787	22	5	,	,	PUNCT
dpc-1787	22	6	ribociclib	ribociclib	NOUN
dpc-1787	22	7	,	,	PUNCT
dpc-1787	22	8	selective	selective	ADJ
dpc-1787	22	9	cyclin	cyclin	NOUN
dpc-1787	22	10	-	-	PUNCT
dpc-1787	22	11	dependent	dependent	ADJ
dpc-1787	22	12	kinase	kinase	NOUN
dpc-1787	22	13	4/6	4/6	NUM
dpc-1787	22	14	inhibitors	inhibitor	NOUN
dpc-1787	22	15	,	,	PUNCT
dpc-1787	22	16	breast	breast	NOUN
dpc-1787	22	17	cancer	cancer	NOUN
dpc-1787	22	18	,	,	PUNCT
dpc-1787	22	19	adverse	adverse	ADJ
dpc-1787	22	20	event	event	NOUN
dpc-1787	22	21	citation	citation	NOUN
dpc-1787	22	22	:	:	PUNCT
dpc-1787	22	23	silvestre	silvestre	NOUN
dpc-1787	22	24	-	-	PUNCT
dpc-1787	22	25	torner	torner	NOUN
dpc-1787	22	26	n	n	CCONJ
dpc-1787	22	27	,	,	PUNCT
dpc-1787	22	28	aguilar	aguilar	PROPN
dpc-1787	22	29	-	-	PUNCT
dpc-1787	22	30	martínez	martínez	PROPN
dpc-1787	22	31	a	a	NOUN
dpc-1787	22	32	,	,	PUNCT
dpc-1787	22	33	echarri	echarri	PROPN
dpc-1787	22	34	-	-	PUNCT
dpc-1787	22	35	gonzález	gonzález	PROPN
dpc-1787	22	36	mj	mj	PROPN
dpc-1787	22	37	,	,	PUNCT
dpc-1787	22	38	tabbara	tabbara	PROPN
dpc-1787	22	39	-	-	PUNCT
dpc-1787	22	40	carrascosa	carrascosa	PROPN
dpc-1787	22	41	s	s	PROPN
dpc-1787	22	42	,	,	PUNCT
dpc-1787	22	43	román	román	NOUN
dpc-1787	22	44	-	-	PUNCT
dpc-1787	22	45	sainz	sainz	PROPN
dpc-1787	22	46	j	j	PROPN
dpc-1787	22	47	,	,	PUNCT
dpc-1787	22	48	gruber	gruber	PROPN
dpc-1787	22	49	-	-	PUNCT
dpc-1787	22	50	velasco	velasco	PROPN
dpc-1787	22	51	f.	f.	PROPN
dpc-1787	22	52	ribociclib	ribociclib	PROPN
dpc-1787	22	53	-	-	PUNCT
dpc-1787	22	54	induced	induce	VERB
dpc-1787	22	55	vitiligo	vitiligo	NOUN
dpc-1787	22	56	:	:	PUNCT
dpc-1787	22	57	a	a	DET
dpc-1787	22	58	case	case	NOUN
dpc-1787	22	59	report	report	NOUN
dpc-1787	22	60	.	.	PUNCT
dpc-1787	23	1	dermatol	dermatol	NOUN
dpc-1787	23	2	pract	pract	PROPN
dpc-1787	23	3	concept	concept	NOUN
dpc-1787	23	4	.	.	PUNCT
dpc-1787	24	1	2022;12(2):e2022045	2022;12(2):e2022045	X
dpc-1787	24	2	.	.	PUNCT
dpc-1787	24	3	doi	doi	NOUN
dpc-1787	24	4	:	:	PUNCT
dpc-1787	24	5	https://doi.org/10.5826/dpc.1202a45	https://doi.org/10.5826/dpc.1202a45	ADV
dpc-1787	24	6	accepted	accept	VERB
dpc-1787	24	7	:	:	PUNCT
dpc-1787	24	8	july	july	PROPN
dpc-1787	24	9	29	29	NUM
dpc-1787	24	10	,	,	PUNCT
dpc-1787	24	11	2021	2021	NUM
dpc-1787	24	12	;	;	PUNCT
dpc-1787	24	13	published	publish	VERB
dpc-1787	24	14	:	:	PUNCT
dpc-1787	24	15	april	april	PROPN
dpc-1787	24	16	,	,	PUNCT
dpc-1787	24	17	2022	2022	NUM
dpc-1787	24	18	copyright	copyright	NOUN
dpc-1787	24	19	:	:	PUNCT
dpc-1787	24	20	©	©	PROPN
dpc-1787	24	21	2022	2022	NUM
dpc-1787	24	22	silvestre	silvestre	NOUN
dpc-1787	24	23	-	-	PUNCT
dpc-1787	24	24	torner	torner	NOUN
dpc-1787	24	25	et	et	PROPN
dpc-1787	24	26	al	al	PROPN
dpc-1787	24	27	.	.	PUNCT
dpc-1787	25	1	this	this	PRON
dpc-1787	25	2	is	be	AUX
dpc-1787	25	3	an	an	DET
dpc-1787	25	4	open	open	ADJ
dpc-1787	25	5	-	-	PUNCT
dpc-1787	25	6	access	access	NOUN
dpc-1787	25	7	article	article	NOUN
dpc-1787	25	8	distributed	distribute	VERB
dpc-1787	25	9	under	under	ADP
dpc-1787	25	10	the	the	DET
dpc-1787	25	11	terms	term	NOUN
dpc-1787	25	12	of	of	ADP
dpc-1787	25	13	the	the	DET
dpc-1787	25	14	creative	creative	ADJ
dpc-1787	25	15	commons	common	NOUN
dpc-1787	25	16	attribution	attribution	NOUN
dpc-1787	25	17	license	license	NOUN
dpc-1787	25	18	by	by	ADP
dpc-1787	25	19	-	-	PUNCT
dpc-1787	25	20	nc-4.0	nc-4.0	NOUN
dpc-1787	25	21	,	,	PUNCT
dpc-1787	25	22	which	which	PRON
dpc-1787	25	23	permits	permit	VERB
dpc-1787	25	24	unrestricted	unrestricted	ADJ
dpc-1787	25	25	noncommercial	noncommercial	ADJ
dpc-1787	25	26	use	use	NOUN
dpc-1787	25	27	,	,	PUNCT
dpc-1787	25	28	distribution	distribution	NOUN
dpc-1787	25	29	,	,	PUNCT
dpc-1787	25	30	and	and	CCONJ
dpc-1787	25	31	reproduction	reproduction	NOUN
dpc-1787	25	32	in	in	ADP
dpc-1787	25	33	any	any	DET
dpc-1787	25	34	medium	medium	NOUN
dpc-1787	25	35	,	,	PUNCT
dpc-1787	25	36	provided	provide	VERB
dpc-1787	25	37	the	the	DET
dpc-1787	25	38	original	original	ADJ
dpc-1787	25	39	authors	author	NOUN
dpc-1787	25	40	and	and	CCONJ
dpc-1787	25	41	source	source	NOUN
dpc-1787	25	42	are	be	AUX
dpc-1787	25	43	credited	credit	VERB
dpc-1787	25	44	.	.	PUNCT
dpc-1787	26	1	funding	funding	NOUN
dpc-1787	26	2	:	:	PUNCT
dpc-1787	26	3	none	none	NOUN
dpc-1787	26	4	.	.	PUNCT
dpc-1787	27	1	competing	compete	VERB
dpc-1787	27	2	interests	interest	NOUN
dpc-1787	27	3	:	:	PUNCT
dpc-1787	27	4	none	none	NOUN
dpc-1787	27	5	.	.	PUNCT
dpc-1787	28	1	authorship	authorship	NOUN
dpc-1787	28	2	:	:	PUNCT
dpc-1787	28	3	all	all	DET
dpc-1787	28	4	authors	author	NOUN
dpc-1787	28	5	have	have	AUX
dpc-1787	28	6	contributed	contribute	VERB
dpc-1787	28	7	significantly	significantly	ADV
dpc-1787	28	8	to	to	ADP
dpc-1787	28	9	this	this	DET
dpc-1787	28	10	publication	publication	NOUN
dpc-1787	28	11	.	.	PUNCT
dpc-1787	29	1	corresponding	correspond	VERB
dpc-1787	29	2	author	author	NOUN
dpc-1787	29	3	:	:	PUNCT
dpc-1787	29	4	nicolás	nicolás	PROPN
dpc-1787	29	5	silvestre	silvestre	PROPN
dpc-1787	29	6	torner	torner	NOUN
dpc-1787	29	7	,	,	PUNCT
dpc-1787	29	8	department	department	NOUN
dpc-1787	29	9	of	of	ADP
dpc-1787	29	10	dermatology	dermatology	NOUN
dpc-1787	29	11	.	.	PUNCT
dpc-1787	30	1	hospital	hospital	NOUN
dpc-1787	30	2	universitario	universitario	PROPN
dpc-1787	30	3	severo	severo	PROPN
dpc-1787	30	4	ochoa	ochoa	PROPN
dpc-1787	30	5	.	.	PUNCT
dpc-1787	30	6	avenida	avenida	PROPN
dpc-1787	30	7	de	de	PROPN
dpc-1787	30	8	orellana	orellana	PROPN
dpc-1787	30	9	.	.	PUNCT
dpc-1787	30	10	zip	zip	NOUN
dpc-1787	30	11	code	code	PROPN
dpc-1787	30	12	28911	28911	NUM
dpc-1787	30	13	.	.	PUNCT
dpc-1787	31	1	leganés	leganés	NOUN
dpc-1787	31	2	(	(	PUNCT
dpc-1787	31	3	madrid	madrid	PROPN
dpc-1787	31	4	)	)	PUNCT
dpc-1787	31	5	.	.	PUNCT
dpc-1787	32	1	spain	spain	PROPN
dpc-1787	32	2	.	.	PUNCT
dpc-1787	33	1	e	e	X
dpc-1787	33	2	-	-	NOUN
dpc-1787	33	3	mail	mail	NOUN
dpc-1787	33	4	:	:	PUNCT
dpc-1787	33	5	nicolassilvestretorner@gmail.com	nicolassilvestretorner@gmail.com	X
dpc-1787	33	6	2	2	NUM
dpc-1787	33	7	research	research	NOUN
dpc-1787	33	8	letter	letter	NOUN
dpc-1787	33	9	|	|	ADV
dpc-1787	33	10	dermatol	dermatol	ADJ
dpc-1787	33	11	pract	pract	NOUN
dpc-1787	33	12	concept	concept	NOUN
dpc-1787	33	13	.	.	PUNCT
dpc-1787	34	1	2022;12(2):e2022045	2022;12(2):e2022045	NUM
dpc-1787	34	2	figure	figure	NOUN
dpc-1787	34	3	1	1	NUM
dpc-1787	34	4	.	.	PUNCT
dpc-1787	35	1	(	(	PUNCT
dpc-1787	35	2	a	a	DET
dpc-1787	35	3	,	,	PUNCT
dpc-1787	35	4	b	b	NOUN
dpc-1787	35	5	)	)	PUNCT
dpc-1787	35	6	clinical	clinical	ADJ
dpc-1787	35	7	images	image	NOUN
dpc-1787	35	8	.	.	PUNCT
dpc-1787	36	1	achromic	achromic	ADJ
dpc-1787	36	2	sharply	sharply	ADV
dpc-1787	36	3	demarcated	demarcate	VERB
dpc-1787	36	4	macules	macule	NOUN
dpc-1787	36	5	in	in	ADP
dpc-1787	36	6	the	the	DET
dpc-1787	36	7	neck	neck	NOUN
dpc-1787	36	8	,	,	PUNCT
dpc-1787	36	9	cheeks	cheek	NOUN
dpc-1787	36	10	and	and	CCONJ
dpc-1787	36	11	ears	ear	NOUN
dpc-1787	36	12	,	,	PUNCT
dpc-1787	36	13	with	with	SCONJ
dpc-1787	36	14	affectation	affectation	NOUN
dpc-1787	36	15	of	of	ADP
dpc-1787	36	16	the	the	DET
dpc-1787	36	17	hair	hair	NOUN
dpc-1787	36	18	follicle	follicle	NOUN
dpc-1787	36	19	.	.	PUNCT
dpc-1787	37	1	figure	figure	NOUN
dpc-1787	37	2	2	2	NUM
dpc-1787	37	3	.	.	PUNCT
dpc-1787	37	4	clinical	clinical	ADJ
dpc-1787	37	5	image	image	NOUN
dpc-1787	37	6	.	.	PUNCT
dpc-1787	38	1	bright	bright	ADJ
dpc-1787	38	2	white	white	ADJ
dpc-1787	38	3	and	and	CCONJ
dpc-1787	38	4	sharply	sharply	ADV
dpc-1787	38	5	delineated	delineated	ADJ
dpc-1787	38	6	lesions	lesion	NOUN
dpc-1787	38	7	showed	show	VERB
dpc-1787	38	8	with	with	ADP
dpc-1787	38	9	wood	wood	NOUN
dpc-1787	38	10	lamp	lamp	NOUN
dpc-1787	38	11	.	.	PUNCT
dpc-1787	39	1	vitiligo	vitiligo	VERB
dpc-1787	39	2	-	-	PUNCT
dpc-1787	39	3	like	like	ADJ
dpc-1787	39	4	lesions	lesion	NOUN
dpc-1787	39	5	have	have	AUX
dpc-1787	39	6	been	be	AUX
dpc-1787	39	7	described	describe	VERB
dpc-1787	39	8	in	in	ADP
dpc-1787	39	9	patients	patient	NOUN
dpc-1787	39	10	treated	treat	VERB
dpc-1787	39	11	with	with	ADP
dpc-1787	39	12	cdk	cdk	PROPN
dpc-1787	39	13	4/6is	4/6is	NUM
dpc-1787	39	14	too	too	ADV
dpc-1787	39	15	,	,	PUNCT
dpc-1787	39	16	mostly	mostly	ADV
dpc-1787	39	17	in	in	ADP
dpc-1787	39	18	relation	relation	NOUN
dpc-1787	39	19	to	to	PART
dpc-1787	39	20	ribociclib	ribociclib	VERB
dpc-1787	39	21	[	[	X
dpc-1787	39	22	2	2	NUM
dpc-1787	39	23	]	]	PUNCT
dpc-1787	39	24	.	.	PUNCT
dpc-1787	40	1	although	although	SCONJ
dpc-1787	40	2	the	the	DET
dpc-1787	40	3	pathogenic	pathogenic	ADJ
dpc-1787	40	4	mechanism	mechanism	NOUN
dpc-1787	40	5	between	between	ADP
dpc-1787	40	6	cdk	cdk	PROPN
dpc-1787	40	7	4/6is	4/6is	NUM
dpc-1787	40	8	and	and	CCONJ
dpc-1787	40	9	vitiligo	vitiligo	NOUN
dpc-1787	40	10	is	be	AUX
dpc-1787	40	11	still	still	ADV
dpc-1787	40	12	unclear	unclear	ADJ
dpc-1787	40	13	,	,	PUNCT
dpc-1787	40	14	it	it	PRON
dpc-1787	40	15	has	have	AUX
dpc-1787	40	16	been	be	AUX
dpc-1787	40	17	classified	classify	VERB
dpc-1787	40	18	as	as	ADP
dpc-1787	40	19	a	a	DET
dpc-1787	40	20	class	class	NOUN
dpc-1787	40	21	-	-	PUNCT
dpc-1787	40	22	related	relate	VERB
dpc-1787	40	23	ae	ae	PROPN
dpc-1787	40	24	.	.	PUNCT
dpc-1787	41	1	the	the	DET
dpc-1787	41	2	cell	cell	NOUN
dpc-1787	41	3	-	-	PUNCT
dpc-1787	41	4	cycle	cycle	NOUN
dpc-1787	41	5	arrest	arrest	NOUN
dpc-1787	41	6	and	and	CCONJ
dpc-1787	41	7	consequent	consequent	ADJ
dpc-1787	41	8	apoptosis	apoptosis	NOUN
dpc-1787	41	9	induced	induce	VERB
dpc-1787	41	10	by	by	ADP
dpc-1787	41	11	cdk	cdk	PROPN
dpc-1787	41	12	4/6is	4/6is	NUM
dpc-1787	42	1	[	[	X
dpc-1787	42	2	1	1	NUM
dpc-1787	42	3	]	]	PUNCT
dpc-1787	42	4	,	,	PUNCT
dpc-1787	42	5	may	may	AUX
dpc-1787	42	6	lead	lead	VERB
dpc-1787	42	7	to	to	ADP
dpc-1787	42	8	a	a	DET
dpc-1787	42	9	premature	premature	ADJ
dpc-1787	42	10	death	death	NOUN
dpc-1787	42	11	of	of	ADP
dpc-1787	42	12	melanocytes	melanocyte	NOUN
dpc-1787	42	13	,	,	PUNCT
dpc-1787	42	14	that	that	SCONJ
dpc-1787	42	15	clinically	clinically	ADV
dpc-1787	42	16	manifests	manifest	VERB
dpc-1787	42	17	as	as	ADP
dpc-1787	42	18	achromic	achromic	ADJ
dpc-1787	42	19	lesions	lesion	NOUN
dpc-1787	42	20	.	.	PUNCT
dpc-1787	43	1	the	the	DET
dpc-1787	43	2	prognostic	prognostic	ADJ
dpc-1787	43	3	meaning	meaning	NOUN
dpc-1787	43	4	of	of	ADP
dpc-1787	43	5	vitiligo	vitiligo	ADJ
dpc-1787	43	6	lesions	lesion	NOUN
dpc-1787	43	7	in	in	ADP
dpc-1787	43	8	patients	patient	NOUN
dpc-1787	43	9	treated	treat	VERB
dpc-1787	43	10	with	with	ADP
dpc-1787	43	11	cdk	cdk	PROPN
dpc-1787	43	12	4/6is	4/6is	PROPN
dpc-1787	43	13	remains	remain	VERB
dpc-1787	43	14	still	still	ADV
dpc-1787	43	15	unclear	unclear	ADJ
dpc-1787	43	16	.	.	PUNCT
dpc-1787	44	1	treatment	treatment	NOUN
dpc-1787	44	2	of	of	ADP
dpc-1787	44	3	vitiligo	vitiligo	NOUN
dpc-1787	44	4	induced	induce	VERB
dpc-1787	44	5	by	by	ADP
dpc-1787	44	6	cdk	cdk	PROPN
dpc-1787	44	7	4/6i	4/6i	NUM
dpc-1787	44	8	is	be	AUX
dpc-1787	44	9	challenging	challenging	ADJ
dpc-1787	44	10	.	.	PUNCT
dpc-1787	45	1	similar	similar	ADJ
dpc-1787	45	2	therapeutic	therapeutic	ADJ
dpc-1787	45	3	strategies	strategy	NOUN
dpc-1787	45	4	followed	follow	VERB
dpc-1787	45	5	in	in	ADP
dpc-1787	45	6	other	other	ADJ
dpc-1787	45	7	vitiligo	vitiligo	NOUN
dpc-1787	45	8	patients	patient	NOUN
dpc-1787	45	9	can	can	AUX
dpc-1787	45	10	be	be	AUX
dpc-1787	45	11	performed	perform	VERB
dpc-1787	45	12	.	.	PUNCT
dpc-1787	46	1	however	however	ADV
dpc-1787	46	2	,	,	PUNCT
dpc-1787	46	3	immunosuppressants	immunosuppressant	NOUN
dpc-1787	46	4	and	and	CCONJ
dpc-1787	46	5	biological	biological	ADJ
dpc-1787	46	6	therapies	therapy	NOUN
dpc-1787	46	7	should	should	AUX
dpc-1787	46	8	be	be	AUX
dpc-1787	46	9	avoided	avoid	VERB
dpc-1787	46	10	in	in	ADP
dpc-1787	46	11	oncological	oncological	ADJ
dpc-1787	46	12	patients	patient	NOUN
dpc-1787	46	13	.	.	PUNCT
dpc-1787	47	1	partial	partial	ADJ
dpc-1787	47	2	response	response	NOUN
dpc-1787	47	3	has	have	AUX
dpc-1787	47	4	been	be	AUX
dpc-1787	47	5	achieved	achieve	VERB
dpc-1787	47	6	with	with	ADP
dpc-1787	47	7	topical	topical	ADJ
dpc-1787	47	8	immunosuppressants	immunosuppressant	NOUN
dpc-1787	47	9	in	in	ADP
dpc-1787	47	10	combination	combination	NOUN
dpc-1787	47	11	with	with	ADP
dpc-1787	47	12	oral	oral	ADJ
dpc-1787	47	13	corticosteroids	corticosteroid	NOUN
dpc-1787	47	14	[	[	X
dpc-1787	47	15	2	2	NUM
dpc-1787	47	16	]	]	PUNCT
dpc-1787	47	17	.	.	PUNCT
dpc-1787	48	1	conlusions	conlusions	PROPN
dpc-1787	48	2	depigmentation	depigmentation	NOUN
dpc-1787	48	3	may	may	AUX
dpc-1787	48	4	cause	cause	VERB
dpc-1787	48	5	psychological	psychological	ADJ
dpc-1787	48	6	distress	distress	NOUN
dpc-1787	48	7	and	and	CCONJ
dpc-1787	48	8	may	may	AUX
dpc-1787	48	9	decreased	decrease	VERB
dpc-1787	48	10	quality	quality	NOUN
dpc-1787	48	11	of	of	ADP
dpc-1787	48	12	life	life	NOUN
dpc-1787	48	13	.	.	PUNCT
dpc-1787	49	1	therefore	therefore	ADV
dpc-1787	49	2	,	,	PUNCT
dpc-1787	49	3	oncological	oncological	ADJ
dpc-1787	49	4	patients	patient	NOUN
dpc-1787	49	5	treated	treat	VERB
dpc-1787	49	6	with	with	ADP
dpc-1787	49	7	cdk	cdk	NOUN
dpc-1787	49	8	4/6is	4/6is	PRON
dpc-1787	49	9	should	should	AUX
dpc-1787	49	10	be	be	AUX
dpc-1787	49	11	informed	inform	VERB
dpc-1787	49	12	about	about	ADP
dpc-1787	49	13	this	this	DET
dpc-1787	49	14	potential	potential	ADJ
dpc-1787	49	15	ae	ae	PROPN
dpc-1787	49	16	and	and	CCONJ
dpc-1787	49	17	should	should	AUX
dpc-1787	49	18	be	be	AUX
dpc-1787	49	19	referred	refer	VERB
dpc-1787	49	20	to	to	ADP
dpc-1787	49	21	a	a	DET
dpc-1787	49	22	dermatologist	dermatologist	NOUN
dpc-1787	49	23	for	for	ADP
dpc-1787	49	24	accurate	accurate	ADJ
dpc-1787	49	25	diagnosis	diagnosis	NOUN
dpc-1787	49	26	and	and	CCONJ
dpc-1787	49	27	treatment	treatment	NOUN
dpc-1787	49	28	.	.	PUNCT
dpc-1787	50	1	references	reference	NOUN
dpc-1787	50	2	1	1	NUM
dpc-1787	50	3	.	.	PUNCT
dpc-1787	50	4	rascon	rascon	PROPN
dpc-1787	50	5	k	k	PROPN
dpc-1787	50	6	,	,	PUNCT
dpc-1787	50	7	flajc	flajc	VERB
dpc-1787	50	8	g	g	NOUN
dpc-1787	50	9	,	,	PUNCT
dpc-1787	50	10	de	de	X
dpc-1787	50	11	angelis	angelis	X
dpc-1787	50	12	c	c	X
dpc-1787	50	13	,	,	PUNCT
dpc-1787	50	14	liu	liu	PROPN
dpc-1787	50	15	x	x	PROPN
dpc-1787	50	16	,	,	PUNCT
dpc-1787	50	17	trivedi	trivedi	PROPN
dpc-1787	50	18	mv	mv	PROPN
dpc-1787	50	19	,	,	PUNCT
dpc-1787	50	20	ekinci	ekinci	PROPN
dpc-1787	50	21	e.	e.	PROPN
dpc-1787	50	22	ribociclib	ribociclib	PROPN
dpc-1787	50	23	in	in	ADP
dpc-1787	50	24	hr+/her2advanced	hr+/her2advanced	ADJ
dpc-1787	50	25	or	or	CCONJ
dpc-1787	50	26	metastatic	metastatic	ADJ
dpc-1787	50	27	breast	breast	NOUN
dpc-1787	50	28	cancer	cancer	NOUN
dpc-1787	50	29	patients	patient	NOUN
dpc-1787	50	30	.	.	PUNCT
dpc-1787	51	1	ann	ann	PROPN
dpc-1787	51	2	pharmacother	pharmacother	PROPN
dpc-1787	51	3	.	.	PUNCT
dpc-1787	52	1	2019;53(5):501–509	2019;53(5):501–509	X
dpc-1787	52	2	.	.	PUNCT
dpc-1787	52	3	doi	doi	NOUN
dpc-1787	52	4	:	:	PUNCT
dpc-1787	52	5	10.1177/1060028018817904	10.1177/1060028018817904	NUM
dpc-1787	52	6	.	.	PUNCT
dpc-1787	53	1	pmid	pmid	NOUN
dpc-1787	53	2	:	:	PUNCT
dpc-1787	53	3	30522347	30522347	NUM
dpc-1787	53	4	2	2	NUM
dpc-1787	53	5	.	.	PUNCT
dpc-1787	54	1	sollena	sollena	PROPN
dpc-1787	54	2	p	p	X
dpc-1787	54	3	,	,	PUNCT
dpc-1787	54	4	nikolaou	nikolaou	NOUN
dpc-1787	54	5	v	v	NOUN
dpc-1787	54	6	,	,	PUNCT
dpc-1787	54	7	soupos	soupos	NOUN
dpc-1787	54	8	n	n	CCONJ
dpc-1787	54	9	,	,	PUNCT
dpc-1787	54	10	et	et	PROPN
dpc-1787	54	11	al	al	PROPN
dpc-1787	54	12	.	.	PROPN
dpc-1787	54	13	vitiligo	vitiligo	NOUN
dpc-1787	54	14	-	-	PUNCT
dpc-1787	54	15	like	like	ADJ
dpc-1787	54	16	lesions	lesion	NOUN
dpc-1787	54	17	in	in	ADP
dpc-1787	54	18	patients	patient	NOUN
dpc-1787	54	19	with	with	ADP
dpc-1787	54	20	advanced	advanced	ADJ
dpc-1787	54	21	breast	breast	NOUN
dpc-1787	54	22	cancer	cancer	NOUN
dpc-1787	54	23	treated	treat	VERB
dpc-1787	54	24	with	with	ADP
dpc-1787	54	25	cycline	cycline	NOUN
dpc-1787	54	26	-	-	PUNCT
dpc-1787	54	27	dependent	dependent	ADJ
dpc-1787	54	28	kinases	kinase	NOUN
dpc-1787	54	29	4	4	NUM
dpc-1787	54	30	and	and	CCONJ
dpc-1787	54	31	6	6	NUM
dpc-1787	54	32	inhibitors	inhibitor	NOUN
dpc-1787	54	33	.	.	PUNCT
dpc-1787	55	1	breast	breast	NOUN
dpc-1787	55	2	cancer	cancer	NOUN
dpc-1787	55	3	res	re	NOUN
dpc-1787	55	4	treat	treat	NOUN
dpc-1787	55	5	.	.	PUNCT
dpc-1787	56	1	2021;185(1):247	2021;185(1):247	NUM
dpc-1787	56	2	-	-	SYM
dpc-1787	56	3	253	253	NUM
dpc-1787	56	4	.	.	PUNCT
dpc-1787	57	1	doi	doi	NOUN
dpc-1787	57	2	:	:	PUNCT
dpc-1787	57	3	10.1007	10.1007	NUM
dpc-1787	57	4	/	/	SYM
dpc-1787	57	5	s10549	s10549	NOUN
dpc-1787	57	6	-	-	PUNCT
dpc-1787	57	7	020	020	NUM
dpc-1787	57	8	-	-	PUNCT
dpc-1787	57	9	05914	05914	NUM
dpc-1787	57	10	-	-	PUNCT
dpc-1787	57	11	w.	w.	PROPN
dpc-1787	57	12	pmid	pmid	PROPN
dpc-1787	57	13	:	:	PUNCT
dpc-1787	57	14	32914354	32914354	NUM
dpc-1787	57	15	.	.	PUNCT